Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.22
+1.79 (9.21%)
Aug 7, 2025, 4:00 PM - Market closed
Paycor HCM Stock Forecast
Stock Price Forecast
The 2 analysts that cover Paycor HCM stock have a consensus rating of "Strong Buy" and an average price target of $33, which forecasts a 55.51% increase in the stock price over the next year. The lowest target is $31 and the highest is $35.
Price Target: $33.00 (+55.51%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2025.
Analyst Ratings
The average analyst rating for Paycor HCM stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +46.09% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $35 | Hold → Strong Buy | Upgrades | $2 → $35 | +64.94% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
28.53M
from 28.52M
Increased by 0.04%
Revenue Next Year
20.18M
from 28.53M
Decreased by -29.28%
EPS This Year
-5.02
from -6.69
EPS Next Year
-5.75
from -5.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.3M | 43.2M | 124.7M | ||
| Avg | 28.5M | 20.2M | 60.6M | ||
| Low | 8.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 51.7% | 51.5% | 518.0% | ||
| Avg | 0.0% | -29.3% | 200.2% | ||
| Low | -69.1% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.73 | -2.33 | 2.21 | ||
| Avg | -5.02 | -5.75 | -5.08 | ||
| Low | -6.16 | -8.87 | -11.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.